Magenta Therapeutics, Inc. (19) | Intellectual Property (2)

Browse by Subcategory

License Agreements (2)

Recent Contracts

Amendment, effective as of July 4, 2019, pursuant to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research... (Filed With SEC on November 13, 2019)
Letter Agreement, effective as of February 28, 2019, by and between the Registrant and Heidelberg Pharma Research GmbH relating to the Exclusive Research, Development Option and... (Filed With SEC on April 29, 2019)